Neisseria meningitidis type C capsular polysaccharide inhibits lipooligosaccharide-induced cell activation by binding

Can Kocabas1, Nora Katsenelson, Sunita Kanswal

  • 1Laboratory of Bacterial Polysaccharides, Center for Biologics Evaluation and Research, U. S. Food and Drug Administration, 1410 Rockville Pike (HFM-428), Rockville, MD 20852-1448, USA.

Cellular Microbiology
|January 26, 2007
PubMed

Insights

The meningococcal type C capsular polysaccharide (MCPS) blocks immune responses to bacterial lipooligosaccharides (LOS). MCPS inhibits LOS-induced inflammation and immune cell maturation by binding to LOS receptors.

Area of Science:

  • Immunology
  • Microbiology
  • Molecular Biology

Background:

  • Neisseria meningitidis causes systemic diseases by invading mucosal barriers.
  • Activation of the innate immune system by lipooligosaccharides (LOS) is crucial for host defense.
  • Conserved meningococcal molecules are key targets for immune activation.

Purpose of the Study:

  • To investigate the role of meningococcal type C capsular polysaccharide (MCPS) in modulating host immune responses to LOS.
  • To determine the mechanism by which MCPS affects LOS-mediated immune cell activation.
  • To identify potential new virulence properties of meningococcal capsular polysaccharides.

Main Methods:

  • Monocyte and dendritic cell cultures stimulated with LOS.
  • Measurement of cytokine secretion (IL-6, TNF-alpha) and immune cell maturation markers.
  • Analysis of NF-kappaB activation and MAPK signaling pathways (ERK1/2, p38, JNK).
  • Direct binding assays of MCPS to LOS receptor components (LBP, CD14).
  • Functional assays using HEK293 cells expressing TLR4/MD-2 to assess MCPS inhibition of LOS signaling.

Main Results:

  • MCPS significantly inhibited LOS-induced IL-6 and TNF-alpha secretion from monocytes.
  • MCPS blocked LOS-induced maturation of dendritic cells.
  • MCPS suppressed LOS-induced NF-kappaB activation and MAPK signaling.
  • MCPS directly bound to LBP and CD14, inhibiting LOS binding to these receptors.
  • MCPS inhibition of LOS-mediated activation was dependent on CD14 availability.

Conclusions:

  • Meningococcal type C capsular polysaccharide (MCPS) possesses a novel virulence property by inhibiting innate immune responses to LOS.
  • MCPS interferes with the LOS-CD14-TLR4/MD-2 pathway, dampening inflammation and immune cell activation.
  • These findings reveal a mechanism by which Neisseria meningitidis may evade host immunity.

Related Concept Videos

Formation of Lipopolysaccharides01:19

Formation of Lipopolysaccharides

Lipopolysaccharides (LPS) are crucial components of the outer membrane of Gram-negative bacteria, serving both structural and functional roles. It contributes to membrane stability and protects bacteria from host immune responses. LPS is composed of three major regions—lipid A, a core oligosaccharide, and an O antigen. The biosynthesis and assembly of LPS involve a highly coordinated set of enzymatic reactions and transport mechanisms. Additionally, LPS is recognized as an endotoxin, triggering...
Bacterial Meningitis01:24

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Inhibitors Of Virion Release01:25

Inhibitors Of Virion Release

Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...